Indian Journal of Dermatology
E-IJD CORRESPONDENCE
Year
: 2015  |  Volume : 60  |  Issue : 3  |  Page : 323-

Severe granulomatous rosacea in a boy successfully treated with topical azelaic acid


Chikage Mitoma, Masakazu Takahara, Masutaka Furue 
 Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Correspondence Address:
Chikage Mitoma
Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka
Japan




How to cite this article:
Mitoma C, Takahara M, Furue M. Severe granulomatous rosacea in a boy successfully treated with topical azelaic acid.Indian J Dermatol 2015;60:323-323


How to cite this URL:
Mitoma C, Takahara M, Furue M. Severe granulomatous rosacea in a boy successfully treated with topical azelaic acid. Indian J Dermatol [serial online] 2015 [cited 2021 Sep 17 ];60:323-323
Available from: https://www.e-ijd.org/text.asp?2015/60/3/323/156460


Full Text

Dear Editor,

Rosacea is a common inflammatory dermatitis characterized by persistent erythema, telangiectasia, papules or pustules in the central convex area of the face. Its prevalence in children is low. Granulomatous rosacea (GR) is a distinct histological variant of it. [1] We describe here a case of childhood GR successfully treated with oral antibacterial agents followed by topical azelaic acid (AzA).

A 15-year-old Japanese boy presented with erythema on the forehead, lower eyelids, cheeks and perioral region with a symmetrical distribution for several months [Figure 1]a. There were no prior treatments, including topical corticosteroids. Histologically, the lesion on the forehead showed multiple non-caseating epithelioid cell granulomas with multinucleated giant cells in the dermis, accompanied by lymphocytes and histiocytes infiltrating into hair follicle epithelium [Figure 1]b and c]. Grocott, Periodic acid-Schiff (PAS) and Ziehl-Neelsen stains revealed no infectious microorganisms. Laboratory studies, including the levels of angiotensin-converting enzyme and calcium, were all within normal limits. A chest X-ray, cardiac echogram and ophthalmological examination showed no evidence of sarcoidosis. We diagnosed this case as GR. Oral doxycycline at 200 mg and prednisolone at 5 mg a day were administered for 2 weeks, followed by roxithromycin at 300 mg. The lesions started to regress; however, erythema persisted, so topical DRX; AZA; (20% AzA cream) was subsequently started and roxithromycin was discontinued. The cutaneous lesions had almost completely resolved without scarring after 6months [Figure 1]d. The continuous use of topical AzA for a further year prevented any flaring up of the GR.

The histological features of GR are non-caseating epithelioid cell granulomas with or without follicular involvement, although the clinical manifestations vary (1). The differential diagnoses of childhood cases are granulomatous perioral dermatitis (GPD) and sarcoidosis. GPD is a rare self-limited dermatitis classically found in children of Afro-Caribbean descent. [2] As the histology of GPD can be identical to that seen in GR, some researchers have considered GPD and GR to be variants of the same disease in different ages and ethnic groups. [3]{Figure 1}

The specific factors that cause the development of GR remain unclear. In some cases, Demodex folliculorum was detected within the central dilated follicular infundibula or in the center of the granuloma; [1] however, in the present case, it was not found. Besides external factors, recent molecular studies [4] have suggested that GR is associated with altered innate immune responses: Excess cathelicidin peptides in the epidermis and increased serine protease kallikrein 5 activity in the granular and cornified layers may play certain roles in the pathophysiology of rosacea.

A variety of therapeutic approaches are applied for childhood rosacea. Although topical AzA is a standard therapy for mild to medium papulopustular rosacea, to the best of our knowledge, its effectiveness for GR is not fully understood. Besides conventional pharmacologic mechanisms of AzA, including inhibition of microbial survival, modulation of epidermal differentiation and inhibition of reactive oxygen species, [5] recent research [4] has revealed that it can reduce cathelicidin and kallikrein 5 messenger RNA, which prevents inflammatory responses in the skin.

The present case suggests that topical AzA is useful for preventing relapse as well as treating GR in childhood.

References

1SSanchez JL, Berlingeri-Ramos AC, Vazquez Deuno D. Granulomatous Rosacea. Am J Dermatopathol 2008;30:6-9.
2FFrieden IJ, Prose NS, Fletcher V, Turner ML. Granulomatous perioral dermatitis in children. Arch Dermatol 1989;125:369-73.
3LLucas CR, Korman NJ, Gilliam AC. Cutaneous periorificial dermatitis: A variant of granulomatous rosacea in children? J Cutan Med Surg 2009;13:115-8.
4CCoda AB, Hata T, Miller J, Audish D, Kotol P, Two A, et al. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol 2013;69:570-7.
5NNazzaro-Porro M. Azelaic acid. J Am Acad Dermatol 1987;17:1033-41.